GLUT1 and Bcl-xL in relation to erythropoietin in human colorectal adenocarcinomas.

Hepatogastroenterology

Department of Pathology, Maria Sklodowska-Curie Memorial Bialystok Oncology Center, Medical University of Bialystok, Ogrodowa 12, 15-027 Bialystok, Poland.

Published: January 2011

Background/aims: GLUT1 and EPO belong to so called hypoxia-associated markers, which exert cytoprotective actions in the hypoxia suffering cells. In oxygen deficiency Bcl-xL can also be upregulated.

Methodology: Therefore, we detected with immunohistochemistry and compared EPO with expressions of GLUT-1 and antiapoptotic protein Bcl-xL in 125 colorectal cancers. EPO correlated with GLUT-1 in all colorectal cancers (p < 0.001, r = 0.369). EPO expressions also associated with Bcl-xL (p < 0.001, r = 0.591) in all colorectal cancers.

Results: EPO correlated with GLUT-1 and Bcl-xL in subgroups of different nodal status, grading, staging, histopathological type, tumor site, patients' age and gender. However, the statistically significant relationship between EPO and GLUT-1 or Bcl-xL was lost in case of shallower neoplastic extent (pT1+pT2), but it was sustained in subgroup of deeper invading cancers (pT3+pT4) (p < 0.001, r = 0.355 and p < 0.001, r = 0.585, respectively).

Conclusions: High expression of hypoxia dependent proteins (EPO, GLUT-1) indicates hypoxia of examined tissues of colorectal cancers. Cooperation may be reflected among the studied proteins by correlations between hypoxia dependent proteins (EPO vs. GLUT-1). Concerning functional significance of these investigated factors, subsequent promotion of cell survival could be maintained thanks to mutual impact of EPO and Bcl-xL on cellular viability in hypoxic environment of colorectal cancer.

Download full-text PDF

Source

Publication Analysis

Top Keywords

colorectal cancers
12
epo glut-1
12
epo
9
epo expressions
8
epo correlated
8
correlated glut-1
8
glut-1 bcl-xl
8
hypoxia dependent
8
dependent proteins
8
proteins epo
8

Similar Publications

Background: Colorectal cancer (CRC) exhibits a high incidence globally, with the liver being the most common site of distant metastasis. At the time of diagnosis, 20-30% of CRC patients already present with liver metastases. Colorectal liver metastasis (CRLM) is a major cause of mortality among CRC patients.

View Article and Find Full Text PDF

Background: Colorectal cancer (CRC) is a prevalent malignancy worldwide, associated with significant morbidity and mortality. Cyclin-dependent kinase 1 (CDK1) plays a crucial role in cell cycle regulation and has been implicated in various cancers. This study aimed to evaluate the prognostic value of CDK1 in CRC and to identify traditional Chinese medicines (TCM) that can target CDK1 as potential treatments for CRC.

View Article and Find Full Text PDF

Background: Globally, estimates of cancer cases and deaths have increased since 2018, particularly in Latin America and Caribbean countries. In Antigua and Barbuda, understanding the burden of common cancers such as female breast, cervical, colorectal and prostate cancers is critical. This study aimed to assess the incidence, trends, and patterns of these four cancers from 2017 to 2021.

View Article and Find Full Text PDF

GNG2 inhibits brain metastases from colorectal cancer via PI3K/AKT/mTOR signaling pathway.

Sci Rep

January 2025

Department of Gastrointestinal Surgery, Third Xiangya Hospital, Central South University, Changsha, 410006, China.

G-protein gamma subunit 2 (GNG2) plays a vital role in various cellular processes, yet its specific function in colorectal cancer (CRC), particularly in highly invasive cases and brain metastasis, remains unclear. This study identifies GNG2 as a key regulator in metastatic colorectal cancer (mCRC) through bioinformatics analysis and experimental validation. Functional enrichment analyses reveal that GNG2 is related to the PI3K/AKT/mTOR signaling pathway and cell cycle regulation.

View Article and Find Full Text PDF

The β1,4-N-acetylgalactosaminyltransferase 2 (B4GALNT2) which synthesizes the histo-blood group antigen Sd is highly expressed by normal colon, but it is dramatically down-regulated in colorectal cancer (CRC). High B4GALNT2 expression in CRC tissues is a marker of longer survival. The molecular bases of B4GALNT2 inhibition in CRC are largely obscure.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!